Academic / research · France · EU Transparency Register 264764996511-23
Counts here are a floor, never a total: they cover the 665 consultation files tracked so far (57,774 submissions, mostly 2021–26), so an organization's real filing history is larger, not smaller.
Among the 66 academic institutions on this site, they rank #11 by legislative files engaged, a count of participation, not a measure of influence.
Self-declared to the EU Transparency Register (snapshot 14 Oct 2026).
Self-declared to the EU Transparency Register (snapshot 14 Oct 2026); cost bands are floors, not audited totals. Reused under Commission Decision 2011/833/EU.
Track INSERM in PolicySpeak: request access →
Work at INSERM? so we know who speaks for it.
INSERM filed 5 positions between 4 Feb 2021 and 15 Jun 2026, across 4 of the 665 legislative files tracked here, attaching a full position paper 2 times.
INSERM fully supports the European Commission’s proposal to strengthen the biotechnology and biomanufacturing sectors in the field of health. The Institute welcomes in particular the Commission’s commitment to tackle the fragmentation and regulatory complexity that are currently holding back the development of this sector in Europe.
Filed in French · English published by the European Commission
Very important topic, approached in great detail. Interoperability is a key aspect in data science and health. Also patient access to own data is critical and not often accounted for in the health data management systems. This issue listed in the text is critical: "potential administrative burden and complexity linked to the implementation of this legislation will be assessed".
As a future user of the HealthDCAT-AP standard, INSERM would like to thank the Commission for giving us the opportunity to provide feedback on the amendments to Article 77. We would, however, like to draw attention to several points which currently raise questions regarding their implementation.
It is now widely recognized that biodiversity is being severely undermined by the massive use of pesticides, industrialization, soil artificialization, and global warming. The ever-increasing use of pesticides worldwide is particularly being called into question because products are authorized for market release based on tests that are inadequate or even flawed.
It is now recognised that biodiversity is being undermined in competition by the massive use of pesticides, industrialisation, soil lartificialisation and global warming. The use of pesticides, which is still growing worldwide, is particularly marked by the fact that products assessed with insufficient or defective tests have been authorised on the market.
Filed in French · English published by the European Commission
Looking for an argument rather than an organization? Search every submission for a phrase and see everyone who used it.
Put INSERM next to another organization. Same files, same register facts, side by side. Compare →
Organizations that also filed on at least two of the same consultations. A shared interest in the same dossiers, not evidence of coordination, and we do not suggest any.
Showing 5 of 46.
Everything on this page comes from INSERM’s own submissions to the European Commission. We have added nothing and interpreted nothing. If something is wrong or out of date, email info@policyspeak.com and we will correct it. If you are an individual named in a record, our privacy policy sets out your rights to correction, objection and removal.
Quotes are verbatim from submissions published by the European Commission, trimmed to their opening passage and never summarized by a model. Organizations only, never individuals. Reused under Commission Decision 2011/833/EU; the European Commission is not liable for this reuse.